Isolation of Tyrosinase-Specific CD8+ and CD4+ T Cell Clones from the Peripheral Blood of Melanoma Patients Following in Vitro Stimulation with Recombinant Vaccinia Virus

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 4079-4086

  Yee, Cassian ^a,b,d   Gilbert, Mark J ^a   Riddell, Stanley R ^a   Brichard, Vincent G ^c   Fefer, Alexander ^a,b   Thompson, John A ^b   Boon, Thierry ^c   Greenberg, Philip D ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Ludwig Institute of Cancer Research   (Belgium)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOPHENOL MONOOXYGENASE; RECOMBINANT VACCINE; TUMOR ANTIGEN; TUMOR PROTEIN;

ANIMAL; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CERCOPITHECUS; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOLOGY; MELANOMA; VACCINIA VIRUS;

ANIMALS; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; HUMANS; MELANOMA; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VACCINIA VIRUS;

EID: 0030293623     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Greenberg, P. D. 1991. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol. 49:281.
2. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643.
3. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489.
4. Gaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J. J. Gaforio, E. De Plaen, B. Lethe, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921.
5. Van den Eynde, B., O. Peeters, O. De Backer, B. Gaugler, S. Lucas, and T. Boon. 1995. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182:689.
6. Boel, P., C. Wildmann, M. L. Sensi, R. Brasseur, J. C. Renauld, P. Coulie, T. Boon, and P. van der Bruggen. 1995. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2:167.
7. Bakker, A. B., M. W. Schreurs, A. J. de Boer, Y. Kawakami, S. A. Rosenberg, G. J. Adema, and C. G. Figdor. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1005.
8. Kawakami, Y., S. Eliyahu, C. H. Delgado, P. F. Robbins, K. Sakaguchi, E. Appella, J. R. Yannelli, G. J. Adema, T. Miki, and S. A. Rosenberg. 1994. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91:6458.
9. Wang, R. F., P. F. Robbins, Y. Kawakami, X. Q. Kang, and S. A. Rosenberg. 1995. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes [published erratum appears in J. Exp. Med. 1995 Mar 1;181(3):1261]. J. Exp. Med. 181:799.
10. Coulie, P. G., V. Brichard, A. Van Pel, T. Wolfel, J. Schneider, C. Traversari, S. Mattei, E. De Plaen, C. Lurquin, J. P. Szikora, J.-C. Renauld, and T. Boon. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas [see comments]. J. Exp. Med. 180:35.
11. Jim'enez, M., K. Kameyama, W. L. Maloy, Y. Tomita, and V. J. Hearing. 1988. Mammalian tyrosinase: biosynthesis, processing, and modulation by melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. USA 85:3830.
12. Fitzpatrick, T. B., G. Szabo, M. Seiji, and W. C. J. Quevedo. 1979. Biology of the melanin pigmentary system. In Dermatology in General Medicine. T. B. Fitzpatrick, A. Z. Eisen, K. Wolff, I. M. Freedberg, and K. F. Austen, eds. McGraw-Hill, New York, pp. 261-288.
13. Rawles, M. E. 1948. Origin of melanophores and their role in development of color patterns in vertebrates. Physiol. Rev. 28:383.
14. Chen, Y.-T., E. Stockert, S. Tsang, K. A. Coplan, and L. J. Old. 1995. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc. Natl. Acad. Sci. USA 92:8125.
15. Robbins, P. F., M. El-Gamil, Y. Kawakami, E. Stevens, J. R. Yannelli, and S. A. Rosenberg. 1994. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy [published erratum appears in Cancer Res. 1994 Jul 15;54(14):3952]. Cancer Res. 54:3124.
16. Topalian, S. L., L. M. Muul, D. Solomon, and S. A. Rosenberg. 1987. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J. Immunol. Methods 102:127.
17. Rosenberg, S. A., B. S. Packard, P. M. Aebersold, D. Solomon, S. L. Topalian, S. T. Toy, P. Simon, M. T. Lotze, J. C. Yang, C. A. Seipp, C. Simpson, C. Carter, S. Bock, D. Schwartzentruber, J. Wei, and D. White. 1988. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: a preliminary report [see comments]. N. Engl. J. Med. 319:1676.
18. Maleckar, J. R., C. S. Friddell, A. Sferruzza, G. B. Thurman, W. M. Lewko, W. H. West, R. K. Oldham, and J. R. Yannelli. 1989. Activation and expansion of tumor-derived activated cells for therapeutic use. J. Natl. Cancer Inst. 81: 1655.
19. Restifo, N. P., F. Esquivel, Y. Kawakami, J. W. Yewdell, J. J. Mule, S. A. Rosenberg, and J. R. Bennink. 1993. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:265.
20. Mizoguchi, H., J. J. O'Shea, D. L. Longo, C. M. Loeffler, D. W. McVicar, and A. C. Ochoa. 1992. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice [see comments]. Science 258:1795.
21. Cells, E., V. Tsai, C. Crimi, R. DeMars, P. A. Wentworth, R. W. Chesnut, H. M. Grey, A. Sette, and H. M. Serra. 1994. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA 91:2105.
22. Rivoltini, L., Y. Kawakami, K. Sakaguchi, S. Southwood, A. Sette, P. F. Robbins, F. M. Marincola, M. L. Salgaller, J. R. Yannelli, E. Appella, and S. A. Rosenberg. 1995. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 154: 2257.
23. van der Bruggen, P., J. Bastin, T. Gajewski, P. G. Coulie, P. Boel, C. De Smet, C. Traversari, A. Townsend, and T. Boon. 1994. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24:3038.
24. Visseren, M. J. W., A. van Elsas, E. I. H. van der Voort, M. E. Ressing, W. M. Kast, P. I. Schrier, and C. J. M. Melief. 1995. CTL specific for the tyrosinase autoantigen can be induced form healthy donor blood to lyse melanoma cells. J. Immunol. 154:3991.
25. Van Elsas, A., H. W. Nijman, C. E. Van der Minne, J. S. Mourer, W. M. Kast, C. J. Melief, and P. I. Schrier. 1995. Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A*0201. Int. J. Cancer 61:389.
26. Cheever, M. A., W. Chen, M. L. Disis, M. Takahashi, and D. J. Peace. 1993. T-cell immunity to oncogenic proteins including mutated ras and chimeric berabl. Ann. NY Acad. Sci. 690:101.
27. + T lymphocytes against human melanoma: evidence for a shared melanoma antigen presented by HLA-DR15. J. Immunol. 154:772.
28. + cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles. Int. J. Cancer 57:56.
29. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc. Natl. Acad. Sci. USA 91:9461.
30. - T cells: tumor eradication does not require participation of cytotoxic T cells. J. Exp. Med. 161: 1122.
31. + cells: cytolytic T cells can mediate eradication of disseminated leukemia. J. Immunol. 136:1917.
32. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038.
33. Hopps, H. E., B. C. Bernheim, A. Nisalak, J. H. Tijio, and J. E. Smadel. 1963. Biologic characteristics of a continuous kidney cell line derived from the African green monkey. J. Immunol. 91:416.
34. Mackett, M., G. L. Smith, and B. Moss. 1984. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 49:857.
35. Hahn, S., R. Gehri, and P. Erb. 1995. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol. Rev. 146:57.
36. Salgaller, M. L., J. S. Weber, S. Koenig, J. R. Yannelli, and S. A. Rosenberg. 1994. Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Cancer Immunol. Immunother. 39:105.
37. Brichard, V. G., J. Herman, A. Van Pel, C. Wildmann, B. Gaugler, T. Wolfel, T. Boon, and B. Lethe. 1996. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur. J. Immunol. 26:224.
38. Plebanski, M., C. E. Allsopp, M. Aidoo, H. Reyburn, and A. V. Hill. 1995. Induction of peptide-specific primary cytotoxic T lymphocyte responses from human peripheral blood. Eur. J. Immunol. 25:1783.
39. + T cells. J. Immunol. 154:4915.
40. + T-cell immune responses induced by dendritic cells. Immunology 85:467.